Tag: Base-edited CAR T cells

• March 2, 2023

  Biologics development: First leukemia patient given base-edited CAR T cells

  

  base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy was done on a thirteen-year-old patient suffering from relapsed T-cell acute lymphoblastic leukemia (T-ALL) which helped them to achieve remission 28 days later.